Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

Clinical trial NCT07219927 · RECRUITING

Trial details

NCT number: NCT07219927
Sponsor: Supernus Pharmaceuticals, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Parkinson Disease

Start date: 2025-03-31
Primary completion: 2027-08-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.